Based on these studies, it is suggested that treating psoriasis can be accomplished by decreasing the production of inflammatory factors and adjusting NF-κB and STAT signaling pathways to prevent the polarization of M1-type macrophages or infiltration of M(IL-23) cells. This evidence concerns the gene SOAT1 and psoriasis.